DOVA PHARMACEUTICALS INC's ticker is DOVA and the CUSIP is 25985T102. A total of 68 filers reported holding DOVA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,458,000 | +2.5% | 52,187 | -48.3% | 0.00% | 0.0% |
Q2 2019 | $1,423,000 | +183.5% | 100,939 | +502.1% | 0.00% | +100.0% |
Q2 2018 | $502,000 | +103.2% | 16,765 | +64.7% | 0.00% | – |
Q3 2017 | $247,000 | -79.6% | 10,182 | -81.3% | 0.00% | -100.0% |
Q2 2017 | $1,212,000 | – | 54,365 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 453,032 | $13,047,000 | 2.40% |
Fosun International Ltd | 710,000 | $20,448,000 | 1.79% |
Perceptive Advisors | 1,809,015 | $52,099,000 | 1.73% |
Pier Capital, LLC | 160,123 | $4,612,000 | 0.79% |
Virtus ETF Advisers LLC | 11,044 | $318,000 | 0.40% |
Paulson & Co. | 550,681 | $13,192,000 | 0.26% |
CONNING INC. | 50,000 | $1,440,000 | 0.05% |
Virtu Financial LLC | 11,783 | $339,000 | 0.02% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 12,000 | $346,000 | 0.01% |
FMR LLC | 1,884,925 | $54,285,000 | 0.01% |